HCA Healthcare, Inc.

HCA Healthcare, Inc. (HCA) Market Cap

HCA Healthcare, Inc. has a market capitalization of $109.13B.

Financials based on reported quarter end 2025-12-31

Price: $488.00

β–² 5.03 (1.04%)

Market Cap: 109.13B

NYSE Β· time unavailable

CEO: Samuel N. Hazen

Sector: Healthcare

Industry: Medical - Care Facilities

IPO Date: 2011-03-10

Website: https://www.hcahealthcare.com

HCA Healthcare, Inc. (HCA) - Company Information

Market Cap: 109.13B Β· Sector: Healthcare

HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Analyst Sentiment

70%
Buy

Based on 25 ratings

Analyst 1Y Forecast: $497.06

Average target (based on 6 sources)

Consensus Price Target

Low

$425

Median

$525

High

$635

Average

$524

Potential Upside: 7.4%

Price & Moving Averages

Loading chart...

πŸ“˜ Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

πŸ“˜ HCA Healthcare, Inc. (HCA) β€” Investment Overview

🧩 Business Model Overview

HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a vast network of acute care hospitals, outpatient centers, emergency rooms, and related healthcare facilities. The company’s core offerings include inpatient and outpatient medical care, surgical services, critical care, and a range of specialized programs such as cardiovascular, oncology, orthopedics, and women’s health. HCA serves a broad and diverse customer base, spanning privately insured and government-funded patients, employers, and managed care organizations. Its operational footprint extends across multiple states and major metropolitan regions, making it one of the largest and most geographically diversified hospital operators in the country.

πŸ’° Revenue Model & Ecosystem

HCA Healthcare generates revenue through multiple channels, predominantly patient care services billed to commercial insurers, government payors, and self-pay patients. The company earns income from facility-based services such as inpatient admissions, outpatient visits, surgery, diagnostics, laboratory testing, emergency care, and ancillary therapies. Additionally, HCA derives revenue from physician practice management, urgent care, telemedicine, and partnerships with healthcare networks, insurers, and local providers. Its ecosystem also extends to joint ventures, real estate arrangements, and medical group affiliations, contributing to a broad, vertically integrated healthcare platform that supports both enterprise contracts and direct-to-consumer interactions.

🧠 Competitive Advantages

  • Brand strength: HCA is recognized as a trusted provider of high-quality healthcare services, benefiting from widespread brand awareness and established relationships with patients, physicians, and payors.
  • Switching costs: Deep integration with referring physicians, local communities, and managed care organizations fosters loyalty and creates barriers to patient and provider switching.
  • Ecosystem stickiness: HCA’s robust network of facilities and services supports comprehensive, coordinated care deliveryβ€”enhancing patient retention and facilitating cross-referrals within its system.
  • Scale + supply chain leverage: The company’s national presence affords economies of scale, enabling negotiating leverage for supply procurement, technology investments, and payer contracting.

πŸš€ Growth Drivers Ahead

HCA Healthcare is positioned to benefit from several multi-year growth catalysts. Demographic shifts, including an aging population and growing prevalence of chronic illnesses, drive sustained demand for hospital and outpatient services. Strategic expansion into underserved and high-growth regions, investment in specialized care (such as cardiovascular and oncology), and the integration of digital health tools and telemedicine extend HCA’s reach and care capabilities. Ongoing facility upgrades, network acquisitions, and partnerships with physician groups also serve to increase market share and broaden the service portfolio. Furthermore, operational efficiencies and a focus on value-based care may unlock additional profitability as industry payment models evolve.

⚠ Risk Factors to Monitor

HCA faces a variety of risk exposures. Intense competition from regional health systems, non-traditional healthcare entrants, and outpatient care disruptors could pressure volumes and pricing. Regulatory changes in government reimbursement, insurance coverage mandates, or compliance requirements pose ongoing uncertainties. Labor cost inflation, physician shortages, and supply chain disruptions may impact profitability. Additionally, the increasing emphasis on cost-containment by both public and private payors, as well as the potential rise of new care modalities (e.g., at-home services, digital-first providers), could challenge traditional hospital utilization patterns.

πŸ“Š Valuation Perspective

The market generally values HCA Healthcare at a premium relative to many regional hospital operators, reflecting its sizable scale, operational efficiency, and history of steady performance. Its diversified facility network, cash flow resiliency, and proven management track record support a valuation that acknowledges its lower risk profile versus smaller or more geographically concentrated peers. However, sector-specific headwinds and sensitivity to regulatory shifts can introduce periods of valuation volatility compared to non-cyclical healthcare subsectors.

πŸ” Investment Takeaway

HCA Healthcare offers investors exposure to the stable demand dynamics of the U.S. hospital sector, underpinned by a broad service portfolio, strong market positions, and economies of scale. The bullish case centers on demographic-driven growth, robust execution, and the company’s ability to adapt to evolving care models and reimbursement schemes. Conversely, the bear case highlights risks from regulatory policy, ongoing margin pressures, and a competitive landscape increasingly shaped by disruptive care delivery models. Overall, HCA represents a balanced healthcare operator whose advantages must be weighed against the sector’s structural challenges.


⚠ AI-generated research summary β€” not financial advice. Validate using official filings & independent analysis.

HCA delivered a strong Q4 and FY25 with solid volume growth, margin expansion, and robust cash generation. Management raised 2026 capex to support network and digital initiatives and authorized a new $10b buyback while increasing the dividend. Guidance implies stable margins and continued operational strength but embeds sizable headwinds from ACA exchange changes and lower supplemental payments, with a planned $400m resiliency program to partially offset. Overall tone is confident on demand and execution, yet balanced by policy and payer-related uncertainties.

Growth

  • Q4 revenue +6.7% y/y; adjusted EBITDA +~11%; net income +~31%; adjusted EPS +29%
  • 19th straight quarter of volume growth; 2025 same-facility admissions +2.4%, equivalent admissions +2.5%; ER visits +50 bps
  • Same-facility net revenue per equivalent admission (NREPA) +2.9% in Q4; +4.1% for FY 2025
  • FY 2025 consolidated adjusted EBITDA +12.1% y/y; adjusted EBITDA margin +90 bps
  • Approximately 47 million patient encounters in 2025 (record level)

Business Development

  • Expanded hospital capacity, clinical service offerings, and outpatient facilities across networks
  • Invested in network expansion, workforce development, and clinical capabilities
  • Building high-acuity programs, new access points, and new inpatient capacity
  • Advanced AI and digital transformation; strengthened management systems and leadership development

Financials

  • Q4 adjusted EBITDA margin +80 bps y/y, driven by revenue growth, labor management, and other operating expense improvements
  • Q4 same-facility payer mix: commercial equivalent admissions +1.1% (exchanges +2.5%; commercial ex-exchange +~1%), Medicare +3.5%, Medicaid +2.2%
  • Q4 supplemental payments net impact ~flat y/y due to Virginia retro payment
  • FY 2025 same-facility revenue +6.6%; equivalent admissions +2.4%; NREPA +4.1%
  • FY 2025 adjusted EPS +28.5%
  • FY Supplemental payments net benefit +$420m; hurricane-impacted markets +~$125m EBITDA for FY; Q4 hurricane markets +~$150m vs prior-year quarter

Capital & Funding

  • Capex: $1.5b in Q4; $4.9b in 2025; 2026 capex plan raised to $5.0–$5.5b
  • Share repurchases: $2.6b in Q4; $10b in 2025; new $10b authorization; anticipate completing majority of existing authorization in 2026
  • Dividends: $162m in Q4; $679m in 2025; quarterly dividend increased from $0.72 to $0.78 per share
  • Operating cash flow: $2.4b in Q4; $12.6b FY (+20% y/y); leverage at low end of target range

Operations & Strategy

  • Resiliency program targeting ~$400m incremental savings in 2026 via revenue integrity, variable/fixed cost efficiencies, and capacity management
  • Leveraging benchmarking/advanced analytics, AI/automation, and expanded shared services
  • Operational focus on throughput and length of stay in inpatient, ER, and OR; labor efficiency; supply and operating cost actions
  • Contract labor at ~4.2% of SWB in Q4; overall cost trends expected stable; physician cost pressures expected high single-digit growth in 2026

Market & Outlook

  • 2026 guidance: revenue $76.5–$80.0b; adjusted EBITDA $15.55–$16.45b; net income $6.5–$7.0b; EPS $29.01–$31.50
  • 2026 assumptions: equivalent admissions growth 2–3%; margins slightly above 20%; operating cash flow $12–$13b
  • Long-term volume growth expectation of 2–3% affirmed; strong demand across markets
  • No material incremental EBITDA expected from hurricane-impacted markets in 2026

Risks Or Headwinds

  • Health insurance exchange headwind estimated at $600–$900m EBITDA drag in 2026 due to administrative reforms (One Big Beautiful Bill Act) and expiration of enhanced premium tax credits
  • Resiliency initiatives expected to offset ~$(400)m of the exchange headwind
  • Supplemental payment net benefit expected to decline $250–$450m in 2026 (TN reverting to four quarters, TX program pause, VA one-time retro)
  • Policy uncertainty around Medicaid supplemental programs, Rural Health Transformation, and potential approvals of grandfathered applications (not included in guidance)
  • Physician cost pressures high single-digit growth; potential shifts to bronze plans could reduce utilization and increase patient balance collection risk

Sentiment: MIXED

Note: This summary was synthesized by AI from the HCA Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

πŸ“Š AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"For the quarter ending December 31, 2025, HCA reported a revenue of $19.51 billion, with a net income of $1.88 billion and an EPS of $8.14. The company's net margin stands at approximately 9.63%. Free cash flow for the quarter was significant at $870 million. Year-over-year, HCA's share price increased by a substantial 14%. Despite strong cash flow figures, HCA's balance sheet shows a negative total equity of $-2.77 billion, and a high net debt of $49.16 billion, indicating a leveraged financial position. The P/E ratio of 14x suggests a fair valuation, while FCF yield of 3.27% indicates moderate cash generation compared to the market cap."

Revenue Growth

Good

HCA experienced strong revenue growth with $19.51 billion, highlighting robust demand for its healthcare services. The growth rate and stability are supported by its extensive network of healthcare facilities and services.

Profitability

Positive

Profitability is healthy with a net margin of 9.63% and EPS of $8.14. Although margins are solid, the negative equity and ROE of -37.62% suggest room for improvement in financial efficiency.

Cash Flow Quality

Good

The free cash flow of $870 million is impressive, demonstrating strong cash-generating ability. Dividend payouts are modest, aligning with the cash flow strength.

Leverage & Balance Sheet

Fair

The balance sheet reveals significant leverage, with total liabilities exceeding assets, resulting in negative equity. Net debt to equity is highly negative at -10.55, signaling financial risk.

Shareholder Returns

Good

With a 1-year price increase of 14% and consistent dividends, shareholders have seen substantial returns. Stock buybacks also enhance returns, showcasing strong corporate commitment to shareholder value.

Analyst Sentiment & Valuation

Positive

Valuation on January 29, 2026, appears reasonable with a P/E of 14x and a positive market trend. Analyst targets suggest further upside, as consensus targets remain above current prices.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
πŸ“

SEC Filings (HCA)

Β© 2026 Stock Market Info β€” HCA Healthcare, Inc. (HCA) Financial Profile